Clinical Trial Update: Vitamin A and Very Low Birthweight Babies (VitAL) [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial (VitAL) evaluating vitamin A supplementation in very low birthweight preterm infants has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth
• Retinopathy of Prematurity

Drugs mentioned

• Vitamin A (retinol) (retinol)

Snippet

Sponsor: Glasgow Royal Infirmary | Conditions: Preterm Birth, Retinopathy of Prematurity | Phase 4 | Status: COMPLETED